TABLE 3

Demographic Features of the Study Population

CharacteristicEnrolled at TriageEnrolled After TriageNot UsedNo. of Patient Encounters
No. of patients1392825192
No. (%) of patient encountersa158 (73)33 (15)25 (12)216
Age group, %b,c
    0–23 mo70121943
    2–5 y7120955
    6–12 y7815665
    >12 y72131553
Triage acuity, median, 5-point scaled232
Male gender, %b,c721414115
Medical comorbidities, %b,c
    Hematologic malignancy917170
    Nonhematologic malignancy857727
    Bone marrow transplantation946016
    Solid-organ transplantation9010021
    Asplenia100006
    Short gut100004
    Other7624021
    None27294351
Indwelling vascular catheter, %b,c9443109
Presence of neutropenia (absolute neutrophil count < 500), %b,d7616849
Disease location, %b,d,e
    Pneumonia54172935
    Skin/soft-tissue infection3322449
    Bacteremia65171723
    Fungemia100002
    Urinary tract infection55271811
    Meningitis330673
    Otherf81145139
Etiologies, %b,d,e
    Streptococcus pneumoniae250754
    Staphylococcus aureus4314437
    Other Gram-positives100009
    Escherichia coli33333312
    Other Gram-negatives50292114
    Parainfluenza viruses60301010
    H1N1 influenza831706
    Other viruses50252512
    Candida species100003
    Anaerobes050502
    No organism identified82126142
Disposition from ED, %b,d
    ICU542324106
    Intermediate care floor8020010
    Inpatient floor937087
    Discharge home928012
    Died in ED100001
  • a Eighteen patients had 2 encounters; 3 patients had 3 encounters.

  • b Percentages within rows may not sum to 100% as a result of rounding.

  • c Numbers given for unique patients.

  • d Numbers given for individual patient encounters.

  • e Seven children had >1 site of disease, and 11 had >1 infectious agent identified.

  • f “Other” includes no identifiable disease location and viral respiratory infections.